Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold
暂无分享,去创建一个
L. Abrahmsén | J. Feldwisch | V. Tolmachev | A. Orlova | A. Wennborg | M. Sandström | S. Ahlgren | M. Hansson | H. Wållberg | R. Lewsley | H. Wållberg